About
About Sunzen Biotech Berhad
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells traditional Chinese medicine; trades in crude palm oil and derivative products; and manufactures, imports, trades in, exports, and sells bird's nests and related products. In addition, the company retails herbal drinks, foodstuffs, hampers, and related health products. Further, it engages in the wholesale and trading of animal health and nutrition products for livestock, animal beauty, and cosmetic products; and retail, wholesale, distribution, and trading of health and herbal products, as well as manufacturing, trading, marketing, e-commerce, sales of food and beverage nutrition products. Additionally, the company trades in ophthalmic and diagnostic equipment and other related products. The company was formerly known as Sunzen Biotech Berhad and changed its name to Sunzen Group Berhad in December 2024. Sunzen Group Berhad was founded in 1998 and is based in Shah Alam, Malaysia.
Research context
Sunzen Biotech Berhad appears in PyInvesting’s Kuala Lumpur Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- MYR
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Sunzen Biotech Berhad is currently in a long term uptrend where the price is trading 18.2% above its 200 day moving average.
From a valuation standpoint, the stock is 82.9% cheaper than other stocks from the Other sector with a price to sales ratio of 1.1.
Sunzen Biotech Berhad's total revenue sank by 67.2% to $20M since the same quarter in the previous year.
Its net income has increased by 90.7% to $-383K since the same quarter in the previous year.
Finally, its free cash flow fell by 1.6% to $3M since the same quarter in the previous year.
Based on the above factors, Sunzen Biotech Berhad gets an overall score of 3/5.